Non-enrolment of ovarian cancer patients in clinical trials: reasons and background
Author:
Publisher
Elsevier BV
Subject
Oncology,Hematology
Link
http://academic.oup.com/annonc/article-pdf/16/11/1801/302873/mdi367.pdf
Reference31 articles.
1. Factors that influence the recruitment of patients to phase III studies in oncology;Wright;Cancer,2002
2. Barriers to participation in randomized controlled trials: a systematic review;Ross;J Clin Epidemiol,1999
3. Altmann DG for the CONSORT Group. The CONSORT statement: revise recommendations for improving the quality of reports of parallel-group randomised trials;Moher;Lancet,2001
4. on Behalf of the Austrian Breast & Colorectal Cancer Study Group. Impact of participation in randomized clinical trials on survival of women with early stage breast cancer;Gnant;Proc Am Soc Clin Oncol,2000
5. Die Therapie des fortgeschrittenen Ovarialkarzinoms in Deutschland: Welchen Einfluss hat die Teilnahme an klinischen Studien;du Bois;Geburtsh Frauenheilkd,2001
Cited by 43 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. A multicenter retrospective study to assess feasibility, safety and efficacy of first-line carboplatin-paclitaxel versus carboplatin monotherapy in a frail, elderly epithelial ovarian cancer population;International Journal of Gynecologic Cancer;2024-09-03
2. Ovarian cancer in the older patient: where are we now? What to do next?;Therapeutic Advances in Medical Oncology;2023-01
3. Multi-Disciplinary Care Planning of Ovarian Cancer in Older Patients: General Statement—A Position Paper from SOFOG-GINECO-FRANCOGYN-SFPO;Cancers;2022-03-02
4. Validation of the geriatric vulnerability score in older patients with ovarian cancer: an analysis from the GCIG-ENGOT-GINECO EWOC-1 study;The Lancet Healthy Longevity;2022-03
5. European Society of Gynaecological Oncology quality indicators for the surgical treatment of endometrial carcinoma;International Journal of Gynecologic Cancer;2021-11-18
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3